In an aerial view, a customer enters a Walgreens store on January 04, 2024 in San Pablo, California.Walgreens on Thursday reported fiscal third-quarter earnings that fell short of expectations and slashed its full-year adjusted profit outlook, citing a "challenging" environment for pharmacies and U.S. consumers.The retail pharmacy giant now expects fiscal 2024 adjusted earnings of $2.80 to $2.95 per share. That compares with the company's previous outlook of between $3.20 and $3.35 per share."'We assumed.. ...

Walgreens logo is seen on a truck semitrailer in Florida Keys, United States on May 7, 2024. (Photo ... [+] by Jakub Porzycki/NurPhoto via Getty Images)NurPhoto via Getty ImagesWalgreens (NASDAQ: WBA) is scheduled to report its fiscal Q3 2024 results on Thursday, June 27 (Walgreens’ fiscal ends in August). We expect WBA stock to trade higher post the Q3 announcement, with its revenue and earnings expected to be above the street estimates. The company will likely benefit from its cost reduction actions, but ...

In its upcoming report, Walgreens Boots Alliance (WBA) is predicted by Wall Street analysts to post quarterly earnings of $0.68 per share, reflecting a decline of 32% compared to the same period last year. Revenues are forecasted to be $35.96 billion, representing a year-over-year increase of 1.6%.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 0.3% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projecti ...

The market expects Walgreens Boots Alliance (WBA) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended May 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on June 27, 2024, might help the stock move higher if these key numbe ...

The most recent trading session ended with Walgreens Boots Alliance (WBA) standing at $15.55, reflecting a +0.65% shift from the previouse trading day's closing. This change outpaced the S&P 500's 0.04% loss on the day. Elsewhere, the Dow lost 0.15%, while the tech-heavy Nasdaq added 0.12%.The largest U.S. drugstore chain's stock has dropped by 15.76% in the past month, falling short of the Retail-Wholesale sector's gain of 0.37% and the S&P 500's gain of 4.15%.Analysts and investors alike will be keeping a ...

Walgreens stock can't seem to get out of its tailspin.Sometimes it can seem like a stock is a falling knife, where trying to slow its fall is just going to cut you. That's what Walgreens Boots Alliance (WBA -2.45%) investors may be feeling right now. The stock has dropped to levels it hasn't traded at since the 1990s, and it keeps falling lower. The price drop suggests that the market knows that Walgreens faces a tough road ahead.Walgreens is working to regain the market's confidence. With a new CEO, there' ...

In the latest trading session, Walgreens Boots Alliance (WBA) closed at $15.94, marking a +0.63% move from the previous day. The stock's change was more than the S&P 500's daily gain of 0.26%. Meanwhile, the Dow gained 0.18%, and the Nasdaq, a tech-heavy index, added 0.35%.Shares of the largest U.S. drugstore chain witnessed a loss of 7.85% over the previous month, trailing the performance of the Retail-Wholesale sector with its loss of 0.54% and the S&P 500's gain of 3.25%.The investment community will be ...

People wait in in a queue to enter CityMD, a health clinic that offers coronavirus disease (COVID-19) testing, on the Upper West Side as the Omicron coronavirus variant continues to spread in Manhattan, New York City, U.S., December 19, 2021.Walgreens-backed CityMD will pay $12.04 million to settle Covid fraud allegations brought by the Department of Justice, the department announced on Friday.From February 2020 to April 2022, the urgent care provider allegedly obtained fraudulent government reimbursements ...

Walgreens logo is seen at restaurant in Florida Keys, United States on May 7, 2024. (Photo by Jakub ... [+] Porzycki/NurPhoto via Getty Images)NurPhoto via Getty ImagesGiven its better valuation, we believe Walgreens stock (NYSE: WBA) is a better pick than its peer CVS Health stock (NYSE: CVS). WBA stock trades at 0.1x revenues, versus 0.2x for CVS, given the latter’s superior revenue growth, profitability, and financial position. In the sections below, we discuss why we think WBA is a better pick than CVS. ...

enot-poloskun Introduction Walgreens (NASDAQ:WBA) was once a stock I held in my portfolio, excited about the company's turnaround story they started a few years ago. But since then, it hasn't turned out to be great for the company as they have faced headwinds, forcing them to cut the dividend earlier this year. Moreover, during their recent earnings, WBA's cash flows have continued to face downward pressures. Putting into question their ability to pay future dividends, as free cash flow does not cover t ...